000 01240 a2200289 4500
005 20250515092748.0
264 0 _c20080312
008 200803s 0 0 fre d
022 _a1166-7087
024 7 _a10.1016/s1166-7087(07)92405-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIrani, Jacques
245 0 0 _a[Sunitinib versus interferon-alpha in metastatic renal-cell carcinoma].
_h[electronic resource]
260 _bProgres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
_cSep 2007
300 _a996 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aIndoles
_xtherapeutic use
650 0 4 _aInterferon-alpha
_xtherapeutic use
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aPyrroles
_xtherapeutic use
650 0 4 _aSunitinib
773 0 _tProgres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
_gvol. 17
_gno. 5
_gp. 996
856 4 0 _uhttps://doi.org/10.1016/s1166-7087(07)92405-7
_zAvailable from publisher's website
999 _c17488488
_d17488488